Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carmen Mora

Showing results (11-20 of 109) with videos related to

Pageof 11
Sort By:
Contributions to Nephrology|June 11, 2011
Inflammatory pathwaysJuan F Navarro-González, Carmen Mora-Fernández
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 28, 2003
Inflammatory parameters are independently associated with urinary albumin in type 2 diabetes mellitusJuan F Navarro, Carmen Mora, Manuel Maca, et al.
Journal of Pediatric Surgery|February 12, 2022
Robotic-assisted vertical sleeve gastrectomy in adolescents: Do BMI limits apply?Maria Carmen Mora, Karen A Diefenbach, Marc P Michalsky
Journal of the American Society of Nephrology : JASN|May 27, 2005
Additive antiproteinuric effect of pentoxifylline in patients with type 2 diabetes under angiotensin II receptor blockade: a short-term, randomized, controlled trialJuan F Navarro, Carmen Mora, Mercedes Muros, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 29, 2006
Urinary tumour necrosis factor-alpha excretion independently correlates with clinical markers of glomerular and tubulointerstitial injury in type 2 diabetic patientsJuan F Navarro, Carmen Mora, Mercedes Muros, et al.
Kidney International|March 29, 2002
Randomized prospective comparison between erythropoietin and androgens in CAPD patientsJuan F Navarro, Carmen Mora, Manuel Macía, et al.
Nephron. Clinical Practice|December 25, 2003
Effects of atorvastatin on lipid profile and non-traditional cardiovascular risk factors in diabetic patients on hemodialysisJuan F Navarro, Carmen Mora, Mercedes Muros, et al.
Seminars in Dialysis|March 3, 2009
Clinical implications of disordered magnesium homeostasis in chronic renal failure and dialysisJuan F Navarro-González, Carmen Mora-Fernández, Javier García-Pérez
International Urology and Nephrology|March 17, 2010
Erdheim-Chester disease as cause of end-stage renal failure: a case report and review of the literatureJose Emilio Sanchez, Carmen Mora, Manuel Macia, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 6, 2003
Effects of pentoxifylline administration on urinary N-acetyl-beta-glucosaminidase excretion in type 2 diabetic patients: a short-term, prospective, randomized studyJuan F Navarro, Carmen Mora, Mercedes Muros, et al.
Pageof 11

Showing results (11-20 of 109) with videos related to

Sort By:
Pageof 11
Contributions to Nephrology|June 11, 2011
Inflammatory pathwaysJuan F Navarro-González, Carmen Mora-Fernández
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 28, 2003
Inflammatory parameters are independently associated with urinary albumin in type 2 diabetes mellitusJuan F Navarro, Carmen Mora, Manuel Maca, et al.
Journal of Pediatric Surgery|February 12, 2022
Robotic-assisted vertical sleeve gastrectomy in adolescents: Do BMI limits apply?Maria Carmen Mora, Karen A Diefenbach, Marc P Michalsky
Journal of the American Society of Nephrology : JASN|May 27, 2005
Additive antiproteinuric effect of pentoxifylline in patients with type 2 diabetes under angiotensin II receptor blockade: a short-term, randomized, controlled trialJuan F Navarro, Carmen Mora, Mercedes Muros, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 29, 2006
Urinary tumour necrosis factor-alpha excretion independently correlates with clinical markers of glomerular and tubulointerstitial injury in type 2 diabetic patientsJuan F Navarro, Carmen Mora, Mercedes Muros, et al.
Kidney International|March 29, 2002
Randomized prospective comparison between erythropoietin and androgens in CAPD patientsJuan F Navarro, Carmen Mora, Manuel Macía, et al.
Nephron. Clinical Practice|December 25, 2003
Effects of atorvastatin on lipid profile and non-traditional cardiovascular risk factors in diabetic patients on hemodialysisJuan F Navarro, Carmen Mora, Mercedes Muros, et al.
Seminars in Dialysis|March 3, 2009
Clinical implications of disordered magnesium homeostasis in chronic renal failure and dialysisJuan F Navarro-González, Carmen Mora-Fernández, Javier García-Pérez
International Urology and Nephrology|March 17, 2010
Erdheim-Chester disease as cause of end-stage renal failure: a case report and review of the literatureJose Emilio Sanchez, Carmen Mora, Manuel Macia, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 6, 2003
Effects of pentoxifylline administration on urinary N-acetyl-beta-glucosaminidase excretion in type 2 diabetic patients: a short-term, prospective, randomized studyJuan F Navarro, Carmen Mora, Mercedes Muros, et al.
Pageof 11